Vaccine for AIDS and Ebola virus infection

Gary J. Nabel

Research output: Contribution to journalArticle

Abstract

Ebola virus and HIV present challenges for vaccine development because natural immunity to these viruses is difficult to find, and there are no immune correlates of protection in humans. Modern molecular genetic, virologic and immune analyses have been used to rationally identify promising approaches based on animal model and human clinical studies. Improved vaccine candidates have been defined for HIV, and a promising Ebola vaccine have conferred protection in non-human primates. Further evaluation in humans will allow an assessment of their potential efficacy and point the way to the development of more successful vaccines.

Original languageEnglish (US)
Pages (from-to)213-217
Number of pages5
JournalVirus Research
Volume92
Issue number2
DOIs
StatePublished - Apr 1 2003
Externally publishedYes

Fingerprint

Ebola Hemorrhagic Fever
Vaccines
HIV
Ebola Vaccines
Ebolavirus
Innate Immunity
Primates
Molecular Biology
Animal Models
Viruses

Keywords

  • AIDS
  • Ebola virus
  • Filovirus
  • Hemorrhagic fever
  • HIV
  • Immunodeficiency

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Biology
  • Virology

Cite this

Vaccine for AIDS and Ebola virus infection. / Nabel, Gary J.

In: Virus Research, Vol. 92, No. 2, 01.04.2003, p. 213-217.

Research output: Contribution to journalArticle

Nabel, Gary J. / Vaccine for AIDS and Ebola virus infection. In: Virus Research. 2003 ; Vol. 92, No. 2. pp. 213-217.
@article{0b2507237648456195f61cb36246f6cf,
title = "Vaccine for AIDS and Ebola virus infection",
abstract = "Ebola virus and HIV present challenges for vaccine development because natural immunity to these viruses is difficult to find, and there are no immune correlates of protection in humans. Modern molecular genetic, virologic and immune analyses have been used to rationally identify promising approaches based on animal model and human clinical studies. Improved vaccine candidates have been defined for HIV, and a promising Ebola vaccine have conferred protection in non-human primates. Further evaluation in humans will allow an assessment of their potential efficacy and point the way to the development of more successful vaccines.",
keywords = "AIDS, Ebola virus, Filovirus, Hemorrhagic fever, HIV, Immunodeficiency",
author = "Nabel, {Gary J.}",
year = "2003",
month = "4",
day = "1",
doi = "10.1016/S0168-1702(02)00354-4",
language = "English (US)",
volume = "92",
pages = "213--217",
journal = "Virus Research",
issn = "0168-1702",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Vaccine for AIDS and Ebola virus infection

AU - Nabel, Gary J.

PY - 2003/4/1

Y1 - 2003/4/1

N2 - Ebola virus and HIV present challenges for vaccine development because natural immunity to these viruses is difficult to find, and there are no immune correlates of protection in humans. Modern molecular genetic, virologic and immune analyses have been used to rationally identify promising approaches based on animal model and human clinical studies. Improved vaccine candidates have been defined for HIV, and a promising Ebola vaccine have conferred protection in non-human primates. Further evaluation in humans will allow an assessment of their potential efficacy and point the way to the development of more successful vaccines.

AB - Ebola virus and HIV present challenges for vaccine development because natural immunity to these viruses is difficult to find, and there are no immune correlates of protection in humans. Modern molecular genetic, virologic and immune analyses have been used to rationally identify promising approaches based on animal model and human clinical studies. Improved vaccine candidates have been defined for HIV, and a promising Ebola vaccine have conferred protection in non-human primates. Further evaluation in humans will allow an assessment of their potential efficacy and point the way to the development of more successful vaccines.

KW - AIDS

KW - Ebola virus

KW - Filovirus

KW - Hemorrhagic fever

KW - HIV

KW - Immunodeficiency

UR - http://www.scopus.com/inward/record.url?scp=0037383295&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037383295&partnerID=8YFLogxK

U2 - 10.1016/S0168-1702(02)00354-4

DO - 10.1016/S0168-1702(02)00354-4

M3 - Article

C2 - 12686432

AN - SCOPUS:0037383295

VL - 92

SP - 213

EP - 217

JO - Virus Research

JF - Virus Research

SN - 0168-1702

IS - 2

ER -